Pharma exports to touch USD 25 bn by 2014-15

The challenges before the Indian Pharma industry include EU's new directive on falsified medicines, USFDA's increased cost of operations and China's non-tariff barriers, he said, adding that to mitigate them, the government will carry forward Brand India Pharma campaign, launched recently.